Cambeiro Cabre L*, Homs Samso R, Rosello Diez E, Solans Solerdelcoll M, Gine Serven M, Lorenzo Vaquerizo L, Sanchez Cabus S, Moral Duarte A and Gonzalez Lopez JA
Volume5-Issue7
Dates: Received: 2024-06-22 | Accepted: 2024-07-09 | Published: 2024-07-11
Pages: 757-762
Abstract
Introduction: Retroperitoneal sarcomas with Inferior Vena Cava (IVC) involvement are rare cases and complex to manage. Radical surgical resection is the only potentially curative treatment and sometimes clamping of the IVC is necessary, which can cause hemodynamic alterations. In this study, we describe the use of femorojugular bypass with perfusion pump as a technique to optimize the hemodynamic situation during the resection of retroperitoneal sarcomas with IVC involvement.
Methods: We collected data from patients presenting with retroperitoneal sarcomas with IVC involvement operated at the Hospital de la Santa Creu i Sant Pau (Barcelona), a sarcoma referral center, between March 2021 and May 2023. The technical details of the surgical procedures were analyzed, including the IVC involvement, surgical approach to treatment, and the use of femorojugular bypass. Postoperative complications and oncologic outcomes were also recorded.
Results: A total of seven patients diagnosed with retroperitoneal sarcoma with IVC involvement were operated on. In two of the cases, a femorojugular bypass was performed prior to clamping the IVC. In five of the cases, radical resection of the tumor was achieved without leaving macroscopic disease. The mean estimated blood loss was 2.21 L and there was no postoperative mortality. Overall survival was 75% at 12 months with a mean follow-up of 11.86 months.
Conclusion: The use of femorojugular bypass during the resection of retroperitoneal sarcomas with IVC involvement may improve the hemodynamic situation of the patient and allow for complete tumor resection. This multidisciplinary surgical approach in referral centers may be effective in the treatment of this rare disease. However, further studies are needed to confirm these results and to establish standardized management guidelines.
FullText HTML
FullText PDF
DOI: 10.37871/jbres1951
Certificate of Publication
Copyright
© 2024 Cambeiro CL, et al. Distributed under Creative Commons CC-BY 4.0 
How to cite this article
Cambeiro CL, Homs SR, Rosello DE, Solans SM, Gine SM, Lorenzo VL, Sanchez CS, Moral DA, Gonzalez Lopez JA. Surgical Approach to Retroperitoneal Sarcomas with Involvement of the Permeable Inferior Vena Cava: Use of the Femorojugular Bypass. J Biomed Res Environ Sci. 2024 Jul 11; 5(7): 757-762. doi: 10.37871/jbres1951, Article ID: JBRES1951, Available at: https://www. jelsciences.com/articles/jbres1951.pdf
Subject area(s)
References
- Stanley JC, Veith F, Wakefield TW. Current therapy in vascular and endovascular surgery. 5th ed. Elsevier - Health Sciences Division; 2014.
- Gloviczki P, Dalsing MC, Eklöf B, Lurie F, Wakefield TW, Gloviczki ML. Handbook of venous and lymphatic disorders. 4th ed. CRC Press; 2017. doi: 10.1201/9781315382449. 2017.
- Galland B. Rutherford's Vascular Surgery, 7th edn. Ann R Coll Surg Engl. 2011 Mar;93(2):176. doi: 10.1308/003588411X561062. PMCID: PMC3293326.
- Pérez-de-Villar JM, Arjona-Sanchez A, Rufián-Andujar B, Valenzuela-Molina F, Sánchez-Hidalgo JM, Rodriguez-Ortiz L, Casado-Adam A, Viyuela-García C, Rufián-Peña S, Caro-Cuenca T, Moreno-Vega A, Briceño-Delgado J. Surgical treatment of vena cava leiomyosarcomas: Series of cases in a referral center and literature review. Cir Esp (Engl Ed). 2022 Aug;100(8):481-487. doi: 10.1016/j.cireng.2022.05.020. Epub 2022 May 18. PMID: 35597419.
- Wong D, Hockley J, Parys S, Hodder R, Jansen S, Newman M. Current Technology Venous-Venous Bypass Improves the Safety of Resection of Sarcoma and Benign Retroperitoneal Tumours Involving the Inferior Vena Cava. Eur J Vasc Endovasc Surg. 2022 Nov;64(5):575-576. doi: 10.1016/j.ejvs.2022.07.049. Epub 2022 Aug 12. PMID: 35964890.
- Kulaylat MN, Karakousis CP, Doerr RJ, Karamanoukian HL, O'Brien J, Peer R. Leiomyosarcoma of the inferior vena cava: a clinicopathologic review and report of three cases. J Surg Oncol. 1997 Jul;65(3):205-17. doi: 10.1002/(sici)1096-9098(199707)65:3<205::aid-jso11>3.0.co;2-2. PMID: 9236931.
